NCI Rising Scholars: Cancer Research Seminar Series

NCI Rising Scholars: Cancer Research Seminar Series

Center for Cancer Training, National Cancer Institute

The National Cancer Institute (NCI) Center for Cancer Training hosts the virtual NCI Rising Scholars: Cancer Research Seminar Series showcasing the research of early career cancer researchers supported by the NCI.

Across all NCI training programs, we aim to catalyze the development of a workforce capable of advancing cancer research through a scientifically integrated approach. We accomplish this by providing research training and career development activities for scholars inside NCI’s research groups and by supporting funding opportunities for training in cancer research, career development, and research education. This monthly virtual seminar series is an opportunity to highlight the research and the important contributions made by NCI-supported postdoctoral scholars and early career investigators.

Speakers for the year are selected by the NCI Center for Cancer Training, Cancer Training Branch. We identify all first-author research articles each calendar year published by individuals who are postdoctoral scholars at NCI and those who hold active NCI career development awards and cite the NCI award in the article. The field citation rate and number of citations the article has received to date is taken into consideration. We aim to select research areas spanning the cancer continuum across different cancer organ sites. Additionally, we aim to invite speakers from distinct geographical locations throughout the United States.

Speakers
Community
Center for Cancer Training
Center for Cancer Training

September 2025

SuMoTuWeThFrSa
123456
78910111213
14151617181920
21222324252627
282930
Emory University

Multilevel Predictors of Disparities in Ovarian Cancer Outcomes

Dr. Lindsay Collin
Lindsay Collin
Emory University
Thursday, September 18, 2025 6:00 PM (UTC)
RSVP to seminar

October 2025

SuMoTuWeThFrSa
1234
567891011
12131415161718
19202122232425
262728293031

November 2025

SuMoTuWeThFrSa
1
2345678
9101112131415
16171819202122
23242526272829
30
Dana-Farber Cancer Institute
Harvard Medical School

Eligibility criteria and representative cancer clinical trials

Dr. Andrew Hantel MD
Andrew Hantel
Dana-Farber Cancer Institute and Harvard Medical School
Thursday, November 20, 2025 7:00 PM (UTC)
RSVP to seminar

December 2025

SuMoTuWeThFrSa
123456
78910111213
14151617181920
21222324252627
28293031
Division of Cancer Epidemiology and Genetics

An Updated Evaluation of Atrazine-Cancer Incidence Associations among Pesticide Applicators in the Agricultural Health Study Cohort

Richard Remigio
Richard Remigio
Division of Cancer Epidemiology and Genetics
Thursday, December 18, 2025 7:00 PM (UTC)
RSVP to seminar

Published seminars

University of Washington
Fred Hutch Cancer Center

Radiation for high-risk asymptomatic bone metastases – an implementation science perspective

Erin Gillespie, University of Washington and Fred Hutch Cancer Center
National Cancer Institute

Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression and Long-Term Immune Memory

Sanjay Pal, National Cancer Institute
Michigan State University

Systemwide characterization of the ERK program that drives pancreatic cancer

Jennifer E. Klomp, Michigan State University
University of North Carolina at Chapel Hill

Synthetic nicotine descriptors: awareness and impact on perceptions of e-cigarettes among US youth

Sarah Kowitt, University of North Carolina at Chapel Hill
Memorial Sloan Kettering Cancer Center
Rockefeller University

Fc-optimized CD40 Agonistic Antibody Induces Tertiary Lymphoid Structures and Systemic Antitumor Immunity in Metastatic Cancer Patients

Juan C. Osorio, Memorial Sloan Kettering Cancer Center and Rockefeller University
Cedars-Sinai Medical Center

The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients

Arsen Osipov, Cedars-Sinai Medical Center
University of Michigan–Ann Arbor

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

Abhijit Parolia, University of Michigan–Ann Arbor
UC San Diego Health System

Barriers and facilitators of Hispanic/Latino parents caregiving for a childhood cancer survivor: a qualitative study

Carol Ochoa Dominguez, UC San Diego Health System
National Cancer Institute

An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings

Kathryn Kundrod, National Cancer Institute